President and CEO Emil D Kakkis sold $2.9M of Ultragenyx Pharmaceutical Inc.

Sold$2,904,600

$96.82Price

30,000Shares

−1%Stake

What RARE did after the filing

Prices for RARE after this filing aren't in yet.

Traded Mon, Nov 2. Filed Wed, Nov 4, 3:44 PM ET, during the session. Not investment advice.